[EN] DEAMINATION OF ORGANOPHOSPHORUS-NUCLEOSIDES<br/>[FR] DÉSAMINATION DE NUCLÉOSIDES ORGANOPHOSPHORÉS
申请人:INST UNIV DE CIÈNCIA I TECNOLOGIA S A
公开号:WO2016146808A1
公开(公告)日:2016-09-22
The invention relates to a new synthethic process for obtaining compounds of formula (I) from compounds of formula (II) by means of cytidine deaminase enzymes.
[EN] PROCESS FOR THE PREPARATION OF MONO-PROTECTED alpha,omega-DIAMINO ALKANES<br/>[FR] PROCÉDÉ DE PRÉPARATION D'ALPHA, OMÉGA-DIAMINO ALCANES MONO-PROTÉGÉS
申请人:SYNTHON BIOPHARMACEUTICALS BV
公开号:WO2018086993A1
公开(公告)日:2018-05-17
The present invention relates to a process for the synthesis of mono-protected α,ω-diamino alkanes, the use of said proces in a process for the synthesis of a linker drug comprising an α,ω-diamino alkane moiety and the use of the process of the present invention in a process for preparing an antibody-drug conjugate comprising an α,ω-diamino alkane moiety.
[EN] STEREOSELECTIVE PROCESS OF MANUFACTURE OF PURINE PHOSPHORAMIDATES<br/>[FR] PROCÉDÉ STÉRÉOSÉLECTIF DE FABRICATION DE PHOSPHORAMIDATES DE PURINE
申请人:ATEA PHARMACEUTICALS INC
公开号:WO2021216722A1
公开(公告)日:2021-10-28
The present invention provides stereoselective processes of manufacture for the phosphoramidate nucleotide Compound 1 or a pharmaceutically acceptable salt thereof.
INDUSTRIAL METHOD FOR THE PREPARATON OF HIGH-PURITY METHIOZOLIN
申请人:Moghu Research Center Ltd.
公开号:US20150158852A1
公开(公告)日:2015-06-11
Provided is an industrial method for the preparation of [5-(2,6-difluorobenzyloxy)methyl}-4,5-dihydro-5-methyl-3-(3-methylthiophene-2-yl)-isoxazole](common name: methiozolin) represented by Formula 1 that is a herbicidal substance in high-purity.
Poly(organophosphazene) composition for biomaterials
申请人:Korea Institute of Science and Technology
公开号:EP2540764A2
公开(公告)日:2013-01-02
Provided are a use of chemically-crosslinkable, poly(organophosphazene)s for biomaterials, chemically-crosslinkable poly(organophosphazene)s with a physiologically active substance covalently-bonded thereto, a use thereof for biomaterials, and a process for preparing the same. The chemical crosslinkings can be made by UV irradiation, and/or a crosslinker, and/or an additive, and/or an enzyme, and/or a mixing of at least one polymer.